What oral ATP studies show
A 2024 systematic review included five placebo-controlled trials totaling 121 resistance-trained adult men. It found a maximal-strength signal but no clear benefit for maximum repetitions or anaerobic power. The restricted population and small evidence base limit generalization to women, untrained people or chronic fatigue. [1]
Supporting ATP production is a different strategy
ODS explains that creatine supports the phosphocreatine system used to regenerate ATP during short, intense work. That mechanism has relevant exercise evidence. It does not mean every product marketed for mitochondria, NAD or cellular energy has comparable clinical effects, or that more ATP is always a meaningful treatment target. [2]
Choose an outcome before choosing a supplement
Imagine someone wants help with repeated sprints, while another person has new unexplained exhaustion. Those are different problems. The first can consider training and sports-nutrition evidence; the second needs assessment rather than treating an ATP-marketing claim as a diagnosis. The studied oral ATP doses are research descriptions, not a universal regimen. [2][1][3]
| Question | Interpretation |
|---|---|
| Oral ATP | Small specific trial base |
| Creatine | Supports rapid ATP regeneration |
| Chronic fatigue | Needs cause assessment |

Sources for this article
- The Effect of Oral Adenosine Triphosphate (ATP) Supplementation on Anaerobic Exercise in Healthy Resistance-Trained Individuals: A Systematic Review and Meta-Analysis.
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product. - Dietary Supplements for Exercise and Athletic Performance - Health Professional Fact Sheet
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product. - Dietary Supplements: What You Need to Know - Consumer
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.